dr. R.A.P. (Reinier) Raijmakers

Associate Professor - medical
dr. R.A.P. (Reinier) Raijmakers
  • Department of Medical Oncology

Research Output (73)

αβ T-cell graft depletion for allogeneic HSCT in adults with hematological malignancies

De Witte Moniek A., Janssen Anke, Nijssen Klaartje, Karaiskaki Froso, Swanenberg Luuk, van Rhenen Anna, Admiraal Rick, van der Wagen Lotte, Minnema Monique C., Petersen Eefke, Raymakers Reinier A.P., Westinga Kasper, Straetemans Trudy, Halkes Constantijn J.M., Boelens Jaap Jan, Kuball Jurgen 12 jan 2021, In: Blood Advances. 5 , p. 240-249 10 p.

CCN2 (Cellular Communication Network factor 2) in the bone marrow microenvironment, normal and malignant hematopoiesis

Leguit Roos J., Raymakers Reinier A.P., Hebeda Konnie M., Goldschmeding Roel 2021, In: Journal of Cell Communication and Signaling. 15 , p. 25-56 32 p.

EBV-related lymphoma after long-term daratumumab treatment:a case report

Verpoorte-Botden Ilse P G, Minnema Monique C, Raymakers Reinier A P 1 nov 2020, In: Blood cancer journal. 10

Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy:results from the HOVON 109 study

Saberi Hosnijeh Fatemeh, van der Straten Lina, Kater Arnon P., van Oers Marinus H.J., Posthuma Ward F.M., Chamuleau Martine E.D., Bellido Mar, Doorduijn Jeanette K., van Gelder Michel, Hoogendoorn Mels, de Boer Fransien, te Raa G. Doreen, Kerst J. Martijn, Marijt Erik W.A., Raymakers Reinier A.P., Koene Harry R., Schaafsma Martijn R., Dobber Johan A., Tonino Sanne H., Kersting Sabina S., Langerak Anton W., Levin Mark David sep 2020, In: Experimental Hematology. 89 , p. 55-60.e6

Real-world non-interventional long-term post-authorisation safety study of ruxolitinib in myelofibrosis

Barraco Fiorenza, Greil Richard, Herbrecht Raoul, Schmidt Burkhard, Reiter Andreas, Willenbacher Wolfgang, Raymakers Reinier, Liersch Rüdiger, Wroclawska Monika, Pack Robert, Burock Karin, Karumanchi Divyadeep, Gisslinger Heinz 24 jun 2020, In: British Journal of Haematology. 191 , p. 764-774 11 p.

Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome

Niessen F. A., Van Mourik M. S.M., Bruns A. H.W., Raijmakers R. A.P., De Groot M. C.H., Van Der Bruggen T. 27 mei 2020, In: Antimicrobial Resistance and Infection Control. 9 10 p.

Dexamethasone synergizes with MCL-1 inhibition in multiple myeloma through suppression of S6 phosphorylation

Spaan Ingrid, Timmerman Laura, Kimman Thoman, Slomp Anne, Cuenca Marta, Minnema Monique, Raymakers Reinier, Peperzak Victor okt 2019, In: Clinical Lymphoma, Myeloma and Leukemia. 19 , p. E110-E110

Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life:Results in Dutch Patients and Review of the Literature

Slot Stefanie, Raymakers Reinier A P, Schaap Nicolaas, Span Lambert F R, Koene Harry R, Kersting Sabina, Te Boekhorst Peter A W, Westerman Matthijs, Schouten Harry C, Zweegman Sonja okt 2019, In: Clinical Lymphoma, Myeloma and Leukemia. 19 , p. 624-634 11 p.

Cardiac amyloidosis:the need for early diagnosis

Oerlemans M. I.F.J., Rutten K. H.G., Minnema M. C., Raymakers R. A.P., Asselbergs F. W., de Jonge Nicolaas 29 jul 2019, In: Netherlands Heart Journal. 27 , p. 525-536 12 p.

Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes

Langenhorst J. B., van Kesteren C., van Maarseveen E. M., Dorlo T. P. C., Nierkens Stefan, Lindemans C. A., de Witte M. A., van Rhenen A., Raijmakers R., Bierings M., Kuball J., Huitema A. D. R., Boelens J. J. 23 jul 2019, In: Blood Advances. 3 , p. 2179-2187 9 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.